Dahlia R. Weiss - Concepedia

Author

Dahlia R. Weiss

University of California, San Francisco

Also Known As

Dahlia R Weiss, Dahlia R. Weiss, Dahlia Weiss, Dahlia R. Weiss, Weiss R. Dahlia, Weiss, Dahlia R.

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco Stanford University Heptares Therapeutics (United Kingdom)Stanford Medicine Nurix (United States)

About

Dahlia R. Weiss is an author at University of California, San Francisco specializing in natural sciences, engineering, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	6	6	486
2	Engineering	4	4	238
3	Medicine	4	4	310
4	Biochemistry	3	3	253
5	Biomolecular Engineering	1	1	39

Dahlia R. Weiss

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Millisecond dynamics of RNA polymerase II translocation at atomic resolution Daniel‐Adriano Silva, Dahlia R. Weiss, Fátima Pardo Avila, Proceedings of the National Academy of Sciences	2014	154
Structure-based ligand discovery for the protein–protein interface of chemokine receptor CXCR4 Michael M. Mysinger, Dahlia R. Weiss, Joshua J. Ziarek, Proceedings of the National Academy of Sciences	2012	131
Can Morphing Methods Predict Intermediate Structures? Dahlia R. Weiss, Michael Levitt Journal of Molecular Biology Geometric ModelingPattern FormationMorphing StructureEngineeringNatural Sciences	2008	119
Conformation Guides Molecular Efficacy in Docking Screens of Activated β-2 Adrenergic G Protein Coupled Receptor Dahlia R. Weiss, Seungkirl Ahn, Maria F. Sassano, ACS Chemical Biology Drug TargetQuantitative PharmacologyPeptide ScienceDocking ScreensSystems Pharmacology	2013	109
High end GPCR design: crafted ligand design and druggability analysis using protein structure, lipophilic hotspots and explicit water networks Jonathan S. Mason, Andrea Bortolato, Dahlia R. Weiss, In Silico Pharmacology Chemical BiologyMedicinal ChemistryExplicit Water NetworksBiochemistryDrug Design	2013	86
Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton’s Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell Malignancies Daniel Robbins, Mark Noviski, Ying Siow Tan, Journal of Medicinal Chemistry	2024	78
RNA polymerase II trigger loop residues stabilize and position the incoming nucleotide triphosphate in transcription Xuhui Huang, Dong Wang, Dahlia R. Weiss, Proceedings of the National Academy of Sciences Protein AssemblyMolecular BiologyActive Site ConformationGene TranscriptionTranscriptional Regulation	2010	76
Structure-based discovery of selective positive allosteric modulators of antagonists for the M <sub>2</sub> muscarinic acetylcholine receptor Magdalena Korczynska, Mary J. Clark, Céline Valant, Proceedings of the National Academy of Sciences	2018	71
How Hydrophobic Buckminsterfullerene Affects Surrounding Water Structure Dahlia R. Weiss, Tanya M. Raschke, Michael Levitt The Journal of Physical Chemistry B	2008	64
Muscarinic Receptors as Model Targets and Antitargets for Structure-Based Ligand Discovery Andrew C. Kruse, Dahlia R. Weiss, Mario Rossi, Molecular Pharmacology	2013	62

Page 1